Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1457.646
  • +1.677+0.12%
Close Oct 1 16:00 ET
1466.580High1435.579Low
Constituent Stocks: 10Top Rising: VRTX+1.01%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
VRTXVertex Pharmaceuticals
469.7604.680+1.01%1.13M528.61M472.000465.080472.310461.360121.25B120.88B258.10M257.33M+1.46%-2.39%-1.25%-2.52%+18.15%+36.10%+15.45%--0.44%Loss33.822.35%Biotechnology
AAgilent Technologies
146.560-1.684-1.14%1.41M205.78M148.190148.244148.190144.02042.11B41.95B287.33M286.20M+3.47%+6.10%+5.64%+16.44%+2.02%+33.83%+5.95%0.64%0.49%30.4734.982.81%Diagnostics & Research
CRSPCRISPR Therapeutics
45.580-1.400-2.98%1.26M57.47M47.00046.98047.00545.0153.88B3.82B85.17M83.72M-2.59%-8.60%+0.13%-14.37%-26.17%+6.15%-27.19%--1.50%LossLoss4.24%Biotechnology
APLSApellis Pharmaceuticals
27.740-1.100-3.81%5.67M157.44M28.70028.84028.70026.9603.38B2.27B121.77M81.83M-9.79%-21.93%-28.51%-25.05%-51.20%-28.75%-53.66%--6.93%LossLoss6.03%Biotechnology
EDITEditas Medicine
3.270-0.140-4.11%1.77M5.83M3.4403.4103.4403.220269.70M249.02M82.48M76.15M-7.37%-15.28%-6.30%-32.16%-50.68%-55.39%-67.72%--2.33%LossLoss6.45%Biotechnology
BEAMBeam Therapeutics
23.410-1.090-4.45%909.54K21.34M24.40024.50024.40023.1201.93B1.59B82.42M67.81M-5.49%-8.48%-4.06%-1.84%-13.49%+4.56%-14.00%--1.34%LossLoss5.22%Biotechnology
SGMOSangamo Therapeutics
0.824-0.042-4.87%3.71M3.04M0.8600.8660.8690.792171.55M156.23M208.22M189.63M-11.05%-1.16%+1.82%+158.76%+57.23%+44.16%+51.65%--1.96%LossLoss8.87%Biotechnology
NTLAIntellia Therapeutics
19.200-1.350-6.57%2.29M44.51M20.56020.55020.84018.9601.95B1.93B101.58M100.34M-10.57%-14.86%-11.19%-16.30%-23.05%-35.31%-37.03%--2.29%LossLoss9.15%Biotechnology
CRBUCaribou Biosciences
1.830-0.130-6.63%781.72K1.45M1.9501.9601.9551.820165.36M149.07M90.36M81.46M-4.69%-12.86%-7.58%+17.31%-57.93%-60.48%-68.06%--0.96%LossLoss6.89%Biotechnology
BLUEbluebird bio
0.471-0.049-9.39%7.54M3.64M0.5140.5200.5190.47091.28M90.90M193.91M193.13M-5.86%-5.88%-17.03%-49.68%-60.45%-84.36%-65.89%--3.90%LossLoss9.51%Biotechnology

News

Comments

Read more